{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:06:01Z","timestamp":1791345961888,"version":"4.3.1"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant pleural mesothelioma is an asbestos-related neoplasm with poor prognosis, refractory to current therapies, the incidence of which is expected to increase in the next decades. Female gender was identified as a positive prognostic factor among other clinical and biological prognostic markers for malignant mesothelioma, yet a role of estrogen receptors (ERs) has not been studied. Our goal was to investigate ERs expression in malignant mesothelioma and to assess whether their expression correlates with prognosis. Immunohistochemical analysis revealed intense nuclear ER\u03b2 staining in normal pleura that was reduced in tumor tissues. Conversely, neither tumors nor normal pleura stained positive for ER\u03b1. Multivariate analysis of 78 malignant mesothelioma patients with pathologic stage, histologic type, therapy, sex, and age at diagnosis indicated that ER\u03b2 expression is an independent prognostic factor of better survival. Moreover, studies in vitro confirmed that treatment with 17\u03b2-estradiol led to an ER\u03b2-mediated inhibition of malignant mesothelioma cell proliferation as well as p21CIP1 and p27KIP1 up-regulation. Consistently cell growth was suppressed by ER\u03b2 overexpression, causing a G2-M-phase cell cycle arrest, paralleled by cyclin B1 and survivin down-regulation. Our data support the notion that ER\u03b2 acting as a tumor suppressor is of high potential relevance to prediction of disease progression and to therapeutic response of malignant mesothelioma patients. [Cancer Res 2009;69(11):4598\u2013604]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4523","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T07:46:37Z","timestamp":1243842397000},"page":"4598-4604","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Estrogen Receptor-\u03b2 Affects the Prognosis of Human Malignant Mesothelioma"],"prefix":"10.1158","volume":"69","author":[{"given":"Giulia","family":"Pinton","sequence":"first","affiliation":[{"name":"1Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center, University of Piemonte Orientale A. Avogadro, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brunelli","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center, University of Piemonte Orientale A. Avogadro, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Murer","sequence":"additional","affiliation":[{"name":"2Department of Anatomic Pathology, Mestre Hospital, Venezia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Puntoni","sequence":"additional","affiliation":[{"name":"5Italian Mesothelioma Group and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Puntoni","sequence":"additional","affiliation":[{"name":"3Medical Oncology Unit, Galliera Hospital, and Biostatistics Unit, Department of Health Sciences, University of Genoa, Genova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fennell","sequence":"additional","affiliation":[{"name":"4Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gaudino","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center, University of Piemonte Orientale A. Avogadro, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Mutti","sequence":"additional","affiliation":[{"name":"5Italian Mesothelioma Group and"},{"name":"6S. Pietro e Paolo Hospital, Borgosesia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moro","sequence":"additional","affiliation":[{"name":"1Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center, University of Piemonte Orientale A. Avogadro, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,6,1]]},"reference":[{"key":"2022061700290691600_B1","doi-asserted-by":"crossref","unstructured":"Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic. Br J Cancer\u20081999; 79: 666\u201372.","DOI":"10.1038\/sj.bjc.6690105"},{"key":"2022061700290691600_B2","doi-asserted-by":"crossref","unstructured":"Yang H, Bocchetta M, Kroczynska B, et al. TNF-\u03b1 inhibits asbestos-induced cytotoxicity via a NF-\u03baB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A\u20082006; 103: 10397\u2013402.","DOI":"10.1073\/pnas.0604008103"},{"key":"2022061700290691600_B3","doi-asserted-by":"crossref","unstructured":"Kroczynska B, Cutrone R, Bocchetta M, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A\u20082006; 103: 14128\u201333.","DOI":"10.1073\/pnas.0604544103"},{"key":"2022061700290691600_B4","doi-asserted-by":"crossref","unstructured":"Carbone M, Emri S, Dogan AU, et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer\u20082007; 7: 147\u201354.","DOI":"10.1038\/nrc2068"},{"key":"2022061700290691600_B5","doi-asserted-by":"crossref","unstructured":"Steele JP. Prognostic factors for mesothelioma. Hematol Oncol Clin North Am\u20082005; 19: 1041\u201352. Review.","DOI":"10.1016\/j.hoc.2005.09.009"},{"key":"2022061700290691600_B6","doi-asserted-by":"crossref","unstructured":"Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor \u03b1 and \u03b2: impact on human health. Mol Aspects Med\u20082006; 27: 299\u2013402. Review.","DOI":"10.1016\/j.mam.2006.07.001"},{"key":"2022061700290691600_B7","doi-asserted-by":"crossref","unstructured":"Sutherland RL, Reddel RR, Green MD. Effects of estrogens on cell proliferation and cell cycle kinetics: a hypothesis on the cell cycle effects of antiestrogens. Eur J Cancer Clin Oncol\u20081983; 19: 307\u201318.","DOI":"10.1016\/0277-5379(83)90127-X"},{"key":"2022061700290691600_B8","doi-asserted-by":"crossref","unstructured":"Razandi M, Pedram A, Greene GL, et al. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER\u03b1 and ER\u03b2 expressed in Chinese hamster ovary cells. Mol Endocrinol\u20081999; 13: 307\u201319.","DOI":"10.1210\/mend.13.2.0239"},{"key":"2022061700290691600_B9","doi-asserted-by":"crossref","unstructured":"Castoria G, Barone MV, Di Domenico M, et al. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J\u20081999; 18: 2500\u201310.","DOI":"10.1093\/emboj\/18.9.2500"},{"key":"2022061700290691600_B10","doi-asserted-by":"crossref","unstructured":"Castoria G, Migliaccio A, Bilancio A, et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J\u20082001; 20: 6050\u20139.","DOI":"10.1093\/emboj\/20.21.6050"},{"key":"2022061700290691600_B11","doi-asserted-by":"crossref","unstructured":"Marino M, Pallottini V, Trentalance A. Estrogens cause rapid activation of IP3-PKC-\u03b1 signal transduction pathway in HepG2 cells. Biochem Biophys Res Commun\u20081998; 245: 254\u20138.","DOI":"10.1006\/bbrc.1998.8413"},{"key":"2022061700290691600_B12","doi-asserted-by":"crossref","unstructured":"Marino M, Distefano E, Trentalance A, et al. Estradiol-induced IP3 mediate the estrogen receptor activity expressed in human cells. Mol Cell Endocrinol\u20082001; 182: 19\u201326.","DOI":"10.1016\/S0303-7207(01)00556-1"},{"key":"2022061700290691600_B13","doi-asserted-by":"crossref","unstructured":"Song RX, Santen RJ. Apoptotic action of estrogen. Apoptosis\u20082003; 1: 55\u201360.","DOI":"10.1023\/A:1021649019025"},{"key":"2022061700290691600_B14","unstructured":"Lobenhofer EK, Huper G, Iglehart JD, et al. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ\u20082000; 2: 99\u2013110."},{"key":"2022061700290691600_B15","doi-asserted-by":"crossref","unstructured":"Fernando RI, Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell\u20082004; 7: 3266\u201384.","DOI":"10.1091\/mbc.e03-11-0823"},{"key":"2022061700290691600_B16","doi-asserted-by":"crossref","unstructured":"Marino M, Acconcia F, Trentalance A. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell\u20082003; 6: 2583\u201391.","DOI":"10.1091\/mbc.e02-09-0621"},{"key":"2022061700290691600_B17","doi-asserted-by":"crossref","unstructured":"Marino M, Acconcia F, Bresciani F, et al. Distinct non genomic signal transduction pathways controlled by 17\u03b2-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell\u20082002; 10: 3720\u20139.","DOI":"10.1091\/mbc.e02-03-0153"},{"key":"2022061700290691600_B18","doi-asserted-by":"crossref","unstructured":"Weihua Z, Andersson S, Cheng G, et al. Update on estrogen signaling. FEBS Lett\u20082003; 46: 17\u201324.","DOI":"10.1016\/S0014-5793(03)00436-8"},{"key":"2022061700290691600_B19","doi-asserted-by":"crossref","unstructured":"Cheng J, Lee EJ, Madison LD, Lazennec G. Expression of estrogen receptor \u03b2 in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett\u20082004; 566: 169\u201372.","DOI":"10.1016\/j.febslet.2004.04.025"},{"key":"2022061700290691600_B20","doi-asserted-by":"crossref","unstructured":"Paruthiyil S, Parmar H, Kerekatte V, et al. Estrogen receptor \u03b2 inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res\u20082004; 1: 423\u20138.","DOI":"10.1158\/0008-5472.CAN-03-2446"},{"key":"2022061700290691600_B21","doi-asserted-by":"crossref","unstructured":"Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor \u03b2 inhibits 17\u03b2-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A\u20082004; 6: 1566\u201371.","DOI":"10.1073\/pnas.0308319100"},{"key":"2022061700290691600_B22","doi-asserted-by":"crossref","unstructured":"Geraldes P, Sirois MG, Tanguay J-F. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res\u20082003; 93: 399\u2013405.","DOI":"10.1161\/01.RES.0000088640.18462.42"},{"key":"2022061700290691600_B23","doi-asserted-by":"crossref","unstructured":"Kousteni S, Bellido T, Plotkin L, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell\u20082001; 5: 719\u201330.","DOI":"10.1016\/S0092-8674(02)08100-X"},{"key":"2022061700290691600_B24","doi-asserted-by":"crossref","unstructured":"Mori-Abe A, Tsutsumi S, Takahashi K, et al. Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells. J Endocrinol\u20082003; 178: 417\u201326.","DOI":"10.1677\/joe.0.1780417"},{"key":"2022061700290691600_B25","unstructured":"Churg A, Roggli V, Galateau-Salle, et al. Mesothelioma. In: WHO classification, pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon (France): IARC Press; 2004. p. 128\u201336."},{"key":"2022061700290691600_B26","doi-asserted-by":"crossref","unstructured":"Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to ligand-binding assay for predictor response to adjuvant therapy in breast cancer. J Clin Oncol\u20081999; 17: 1474\u201381.","DOI":"10.1200\/JCO.1999.17.5.1474"},{"key":"2022061700290691600_B27","doi-asserted-by":"crossref","unstructured":"Cacciotti P, Libener R, Betta P, et al. SV40 replication in human mesothelial cells induces HGF\/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A\u20082001; 98: 12032\u20137.","DOI":"10.1073\/pnas.211026798"},{"key":"2022061700290691600_B28","doi-asserted-by":"crossref","unstructured":"Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol\u20082000; 20: 1436\u201347.","DOI":"10.1128\/MCB.20.4.1436-1447.2000"},{"key":"2022061700290691600_B29","unstructured":"Di Domenico M, Castoria G, Bilancio A, et al. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res\u20081996; 19: 4516\u201321."},{"key":"2022061700290691600_B30","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc\u20081958; 53: 457\u201381.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"2022061700290691600_B31","doi-asserted-by":"crossref","unstructured":"Cox DR: Regression models and life tables with discussion. J R Stat Soc\u20081972; 34: 187\u201392.","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"2022061700290691600_B32","doi-asserted-by":"crossref","unstructured":"Chang EC, Frasor J, Komm B, et al. Impact of estrogen receptor \u03b2 on gene networks regulated by estrogen receptor \u03b1 in breast cancer cells. Endocrinology\u20082006; 10: 4831\u201342.","DOI":"10.1210\/en.2006-0563"},{"key":"2022061700290691600_B33","doi-asserted-by":"crossref","unstructured":"Steele JP. Prognostic factors in mesothelioma. Semin Oncol\u20082002; 1: 36\u201340. Review.","DOI":"10.1053\/sonc.2002.30299"},{"key":"2022061700290691600_B34","doi-asserted-by":"crossref","unstructured":"Pettersson K, Gustafsson JA. Role of estrogen receptor \u03b2 in estrogen action. Annu Rev Physiol\u20082001; 63: 165\u201392.","DOI":"10.1146\/annurev.physiol.63.1.165"},{"key":"2022061700290691600_B35","doi-asserted-by":"crossref","unstructured":"Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis\u20082000; 21: 427\u201333.","DOI":"10.1093\/carcin\/21.3.427"},{"key":"2022061700290691600_B36","doi-asserted-by":"crossref","unstructured":"Greene GL, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA. Science\u20081986; 231: 1150\u20134.","DOI":"10.1126\/science.3753802"},{"key":"2022061700290691600_B37","doi-asserted-by":"crossref","unstructured":"Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A\u20081996; 93: 5925\u201330.","DOI":"10.1073\/pnas.93.12.5925"},{"key":"2022061700290691600_B38","doi-asserted-by":"crossref","unstructured":"Beato M. Gene regulation by steroid hormones. Cell\u20081989; 56: 335\u201344.","DOI":"10.1016\/0092-8674(89)90237-7"},{"key":"2022061700290691600_B39","doi-asserted-by":"crossref","unstructured":"Matthews J, Gustafsson JA. Estrogen signalling: a subtle balance between ER\u03b1 and ER\u03b2. Mol Interv\u20082003; 3: 281\u201392.","DOI":"10.1124\/mi.3.5.281"},{"key":"2022061700290691600_B40","doi-asserted-by":"crossref","unstructured":"Trupiano JK, Geisinger KR, Willingham MC, et al. Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers. Mod Pathol\u20082004; 4: 476\u201381.","DOI":"10.1038\/modpathol.3800067"},{"key":"2022061700290691600_B41","doi-asserted-by":"crossref","unstructured":"Tsou JA, Galler JS, Wali A, et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer\u20082007; 2: 220\u201330.","DOI":"10.1016\/j.lungcan.2007.06.015"},{"key":"2022061700290691600_B42","doi-asserted-by":"crossref","unstructured":"Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of \u03b1 and \u03b2 estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol\u20082002; 1: 125\u201340.","DOI":"10.1016\/S0303-7207(01)00750-X"},{"key":"2022061700290691600_B43","doi-asserted-by":"crossref","unstructured":"Martel C, Melner MH, Gagne\u0301 D, et al. Widespread tissue distribution of steroid sulfatase, 3\u03b2-hydroxysteroid dehydrogenase\/\u03b45-\u03b44 isomerase (3\u03b2-HSD), 17\u03b2-HSD 5\u03b1-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol\u20081994; 1: 103\u201311.","DOI":"10.1016\/0303-7207(94)90056-6"},{"key":"2022061700290691600_B44","doi-asserted-by":"crossref","unstructured":"Silva CM, Shupnik MA. Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. Mol Endocrinol\u20082007; 7: 1499\u201312. Review.","DOI":"10.1210\/me.2007-0109"},{"key":"2022061700290691600_B45","doi-asserted-by":"crossref","unstructured":"Osborne CK, Shou J, Massarweh S, et al. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res\u20082005; 11: 865\u201370. Review.","DOI":"10.1158\/1078-0432.865s.11.2"},{"key":"2022061700290691600_B46","doi-asserted-by":"crossref","unstructured":"Levin ER. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol\u20082003; 3: 309\u201317. Review.","DOI":"10.1210\/me.2002-0368"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/11\/4598\/2610590\/4598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/11\/4598\/2610590\/4598.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T12:09:57Z","timestamp":1685016597000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/11\/4598\/549612\/Estrogen-Receptor-Affects-the-Prognosis-of-Human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,6,1]]},"published-print":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4523","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}